Clinical Trials Browser

Phase 2 × OTHER × Advanced Non Small Cell Lung Cancer × Clear all

NCT05004974 2024-03-12

Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer

Phase 2 Recruiting

Advanced Non Small Cell Lung Cancer

NCT03652857 2020-02-17

Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer

Phase 2 Completed

Advanced Non Small Cell Lung Cancer